Principal Financial Group
RXII

Principal Financial Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Principal Financial Group’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-31,755
Closed -$11K – 2289
2016
Q3 		$11K Hold
31,755
– – ﹤0.01% 2163
2016
Q2 		$15K Hold
31,755
– – ﹤0.01% 2161
2016
Q1 		$43K Buy
31,755
+4,395
+16% +$5.95K ﹤0.01% 2130
2015
Q4 		$40K Hold
27,360
– – ﹤0.01% 2163
2015
Q3 		$43K Buy
+27,360
New +$43K ﹤0.01% 2146
2014
Q4 		– Sell
-39,418
Closed -$81K – 2299
2014
Q3 		$81K Buy
39,418
+855
+2% +$1.76K ﹤0.01% 2162
2014
Q2 		$118K Sell
38,563
-13,217
-26% -$40.4K ﹤0.01% 2187
2014
Q1 		$129K Buy
+51,780
New +$129K ﹤0.01% 2208

Principal Financial Group's RXII Position: Q4 2016 in Review

Principal Financial Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 31,755 shares — an estimated $11K sold.

Principal Financial Group first reported a position in RXII in Q1 2014 and held it in 8 quarters. The position peaked at $129K in Q1 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Principal Financial Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Principal Financial Group sold 31,755 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $11K.
  • Principal Financial Group first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 8 quarters.
  • Principal Financial Group's GALENA BIOPHARMA INC COM position peaked at $129K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Principal Financial Group's 13F filing for Q4 2016, filed 13 Feb 2017.